Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Kelly R. Bales
Based on 20 articles published since 2010
(Why 20 articles?)
||||
Expertise Level
The expertise of Kelly R. Bales ranks in the
  • Top 1.4%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Aliases Bales, K R   ·   Bales, K   ·   Bales, Kelly R   ·   Bales, Kelly
Work Locations
Details
Most likely:    Hoffman-La Roche      
2019
  • Neuroscience Discovery, Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. Electronic address: · Karuna Therapeutics, Inc., Boston, MA, United States. · Pubmed 31336138
Probable:    Pfizer      
2016
  • Sanders-Brown Center on Aging, Department of Anatomy & Neurobiology, University of Kentucky, Lexington, KY, USA. · Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. · Takeda Pharmaceuticals, Deerfield, IL, USA. · Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. · Department of Neuroscience, Merck, Whitehouse Station, NJ, USA. · Quintiles (formerly), Rockville, MD, USA. · CereSpir, Inc., New York, NY, USA. · Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, ICN Hospital Clinic i Universitari; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Barcelona beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany. · Biogen, Cambridge, MA, USA. · Sanders-Brown Center on Aging, Department of Physiology, University of Kentucky, Lexington, KY, USA. · Independent medical writer, Philadelphia, PA, USA. · Pfizer, Inc. Neuroscience Research Unit, Cambridge, MA, USA. · Pubmed 29067297
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, CT, USA. · Department of Biology, Brigham Young University, Provo, UT, USA. · Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. · Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: · Pubmed 26545630
2015
  • Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA 02139, USA. · Eastern Point Road, Groton, CT 06340, USA. · Pubmed 25582600
2014
  • Department of Biology, Brigham Young University, Provo, Utah, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America. · The Genome Institute, Washington University School of Medicine, St Louis, Missouri, United States of America. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Developmental Biology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America. · Pubmed 25340798
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. · Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Biology, Brigham Young University, Provo, Utah. · Division of Biology & Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Developmental Biology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. Electronic address: · Pubmed 24548642
2012
  • Neuroscience Research Unit, Pfizer, Inc., Groton, CT 06340, USA. · Pubmed 22458501
2010
  • Neuroscience Research Unit, Pfizer Global Research & Development, Groton, CT 06430, USA. · Pubmed 20079752
2013
  • Global Research and Development, Pfizer Inc, Groton, CT 06340, USA. · Pubmed 23334070
  • Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, USA. · Pubmed 23396974
2012
  • Pfizer Worldwide Research and Development, Groton, CT 06340, USA. · Pubmed 22631613
  • MS#220-4546, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, USA. · Pubmed 22562771
  • Rinat, Pfizer Inc., South San Francisco, CA 94080, USA. · Pubmed 22197375
2011
  • PharmaTx Precision Medicine, Pfizer, Pfizer Global R&D, Groton, CT, USA. · Pubmed 22833209
Probable:    Miscellaneous institutions in Boston      
2015
  • Pfizer Worldwide Research & Development , 610 Main Street, Cambridge, Massachusetts 02139, United States. · Pfizer Worldwide Research & Development , Eastern Point Road, Groton, Connecticut 06340, United States. · Pubmed 26005540
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Kelly R. Bales about Alzheimer Disease:

  • Targeting apolipoprotein E for treating Alzheimer's disease. 2019
  • The roles of inflammation and immune mechanisms in Alzheimer's disease. 2016
  • A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. 2016
  • Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability. 2015
  • Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. 2015
  • Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. 2014
  • Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. 2014
  • Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. 2013
  • γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin. 2013
  • The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update. 2012
Show List of Full Article Records
Google Searches

Learn more about Kelly R. Bales using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Hoffman-La Roche
Pfizer
Miscellaneous institutions in Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Hoffman-La Roche
2019
  • Neuroscience Discovery, Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. Electronic address: · Karuna Therapeutics, Inc., Boston, MA, United States. · Pubmed 31336138
Pfizer
2016
  • Sanders-Brown Center on Aging, Department of Anatomy & Neurobiology, University of Kentucky, Lexington, KY, USA. · Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. · Takeda Pharmaceuticals, Deerfield, IL, USA. · Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. · Department of Neuroscience, Merck, Whitehouse Station, NJ, USA. · Quintiles (formerly), Rockville, MD, USA. · CereSpir, Inc., New York, NY, USA. · Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, ICN Hospital Clinic i Universitari; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Barcelona beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany. · Biogen, Cambridge, MA, USA. · Sanders-Brown Center on Aging, Department of Physiology, University of Kentucky, Lexington, KY, USA. · Independent medical writer, Philadelphia, PA, USA. · Pfizer, Inc. Neuroscience Research Unit, Cambridge, MA, USA. · Pubmed 29067297
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, CT, USA. · Department of Biology, Brigham Young University, Provo, UT, USA. · Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. · Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: · Pubmed 26545630
2015
  • Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA 02139, USA. · Eastern Point Road, Groton, CT 06340, USA. · Pubmed 25582600
2014
  • Department of Biology, Brigham Young University, Provo, Utah, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America. · The Genome Institute, Washington University School of Medicine, St Louis, Missouri, United States of America. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Developmental Biology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America. · Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, Missouri, United States of America; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America. · Pubmed 25340798
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. · Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Biology, Brigham Young University, Provo, Utah. · Division of Biology & Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri. · Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Developmental Biology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. · Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. Electronic address: · Pubmed 24548642
2012
  • Neuroscience Research Unit, Pfizer, Inc., Groton, CT 06340, USA. · Pubmed 22458501
2010
  • Neuroscience Research Unit, Pfizer Global Research & Development, Groton, CT 06430, USA. · Pubmed 20079752
2013
  • Global Research and Development, Pfizer Inc, Groton, CT 06340, USA. · Pubmed 23334070
  • Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, USA. · Pubmed 23396974
2012
  • Pfizer Worldwide Research and Development, Groton, CT 06340, USA. · Pubmed 22631613
  • MS#220-4546, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, USA. · Pubmed 22562771
  • Rinat, Pfizer Inc., South San Francisco, CA 94080, USA. · Pubmed 22197375
2011
  • PharmaTx Precision Medicine, Pfizer, Pfizer Global R&D, Groton, CT, USA. · Pubmed 22833209
Miscellaneous institutions in Boston
2015
  • Pfizer Worldwide Research & Development , 610 Main Street, Cambridge, Massachusetts 02139, United States. · Pfizer Worldwide Research & Development , Eastern Point Road, Groton, Connecticut 06340, United States. · Pubmed 26005540
3 Other Locations Show
Yearly article counts 01002222632
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.